Corporate Profile

ThermoGenesis, our device division and a wholly-owned subsidiary of Cesca Therapeutics, is a leading developer of automated technologies for clinical biobanking, point-of-care cell-based therapeutics and cellular processing for immuno-oncology and other clinical applications.

Cesca Clinical, our therapeutics division, leverages our proprietary cellular processing technology platform to develop safe and efficacious point-of-care therapies targeting a broad range of indications with unmet medical needs, including osteoarthritis and critical limb ischemia. Our goal is to establish partnerships to further advance these promising programs.